Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$14.6M
5M shares
52-week range
$1.21 – $13.28
16% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
441.42%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $391.4K | $0 | $0 | $0 | $129.1K |
| Gross profit | −$391.4K | $0 | $0 | $0 | −$129.1K |
| Gross margin | — | — | — | — | — |
| R&D | $15.5M | $8.4M | $4.2M | $2.7M | $537.4K |
| Operating income | −$23.4M | −$116.1M | −$38.6M | −$81.6M | −$18.5M |
| EBITDA | −$26.1M | −$112.9M | −$38.9M | −$85.9M | −$177.2M |
| Net income | −$26.7M | −$113.4M | −$39.7M | −$88.4M | −$178.0M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -45.36 | -172.80 | -56.80 | -72.80 | -86.24 |
Annual figures · source: Financial Modeling Prep
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
www.renovarogroup.comNo one on the platform currently holds LNAI.
No tracked institution reports a position in LNAI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-05-22 | 1-for-8reverse |
| 2025-09-30 | 1-for-10reverse |
No one on the platform has traded LNAI yet.
| $13M |
| — |
| ERNAErnexa Therapeutics Inc. | $7.03 | +0.86% | $2M | — |
| GOVXGeoVax Labs, Inc. | $1.28 | -3.03% | $1M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$LNAI looking to buy this if it breaks 3,25$.
View on StockTwits ↗$LNAI the absolute best 3 minutes you can spend today - NOT trading related :) https://www.youtube.com/watch?v=tXhnkX8GTrY
View on StockTwits ↗$VSTM $LNAI Irrational Price Depressions: The stock plummeted 20.6% in two days immediately after Lunai announced a major cancer immunotherapy research breakthrough The case (Lunai Bioworks, Inc. v. Does 1-50 et al) is progressing through the U.S. District Court for the District of Delaware: - Legal Claims: The complaint asserts three counts: securities fraud under Section 10(b) and Rule 10b-5, market manipulation under Section 9(a), and wire fraud. The company also intends to add civil RICO claims. - Expedited Discovery Granted: On May 20, 2026, a federal magistrate judge established that Lunai provided a prima facie basis for its claims and granted an emergency motion for expedited third-party discovery. - Current Phase: Lunai is actively sub-poenaing clearinghouses, custodian banks, and broker-dealers to force disclosure of hidden short positions and identify the individual wrongdoers https://www.pacermonitor.com/public/case/64616691/Lunai_Bioworks,_Inc_v_Does_150_et_al
View on StockTwits ↗$VSTM Does VSTM have legal grounds to do what $LNAI decided to do ... Lunai Bioworks filed a federal lawsuit in Delaware on May 11, 2026, targeting unidentified "John Doe" naked short sellers to defend and restore suppressed shareholder value. ... the litigation addresses extreme market manipulation that severely disrupted the company’s stock price Evidentiary Foundations of the Lawsuit - company provided substantial trading metrics to demonstrate clear market manipulation, including: Massive Fails-to-Deliver (FTDs): An anomalous accumulation of 29.6 million FTD shares, representing roughly 81.6% of all outstanding shares. Extreme Volume Spikes: Intraday trading volumes peaked on March 17, 2026, reaching 554 million shares, which was 15.3 times the entire outstanding share count in a single day. Irrational Price Depressions: The stock plummeted 20.6% in two days immediately after Lunai announced a major cancer immunotherapy research breakthrough
View on StockTwits ↗@sweddle @LonoTrader @Huskerg @LTverde @CrozrX Wonder if VSTM has legal grounds to do what $LNAI decided to do ... Lunai Bioworks filed a federal lawsuit in Delaware on May 11, 2026, targeting unidentified "John Doe" naked short sellers to defend and restore suppressed shareholder value. ... the litigation addresses extreme market manipulation that severely disrupted the company’s stock price Evidentiary Foundations of the Lawsuit - company provided substantial trading metrics to demonstrate clear market manipulation, including: Massive Fails-to-Deliver (FTDs): An anomalous accumulation of 29.6 million FTD shares, representing roughly 81.6% of all outstanding shares. Extreme Volume Spikes: Intraday trading volumes peaked on March 17, 2026, reaching 554 million shares, which was 15.3 times the entire outstanding share count in a single day. Irrational Price Depressions: The stock plummeted 20.6% in two days immediately after Lunai announced a major cancer immunotherapy research breakthrough
View on StockTwits ↗$LNAI Stengaard it is surprising you still echo their words and follow their tracks positively.You are zero discerning.Even without the short and naked short issues the company is clueless.Biosymetrics is a gem but no sales .Gabe Musso should lead the company .No idea how you remain bullish as you must have bought at a higher price.Are they comepnsatinng you as one of their team.As they do this.. their inner circle recieves monies,the investors lose..The employees they do not care about and never have.
View on StockTwits ↗$LNAI I truly do not understand how anyone can be bulllish.We were promised stock price of USD 100 per share .Sindlev even promised USD 450 per share.Totally megomanic.The original products/therapies from Sehrat are defunct.Ai /Cube which was a great company, they closed--no reason just did.. NP is the real boss over there and that is a person without strategy just a trader boostinghe controlled the market., ,Weinstein is a puppet. The original investors all lost money and without the stock splits the real price at this moment(divided by 8 and then 10) is not even 5 cents.This company is a dead duck in the water and lots of class action suits to follow.Ole /Neil/Sindlev all receive 65 percent extra shares...they did not own hte shares to begin with.
View on StockTwits ↗$LNAI Updated no from Stocktitan: The legal 779,600-share short position represents 34.67% of estimated free float — built in the June 1–13 window at borrow costs of 99.80–99.81% annualised. Two days after this position was established, borrow went to zero (June 15, 11:30 UTC) and has remained there more or less until yesterday . The short sellers paid to rebuild their position and were immediately caught with no exit. Days to cover: 1.8 days at Jun 22 volume (439,859) / 6.1 days at Jun 23 volume (128,157). At 34.67% of estimated tradeable float, this position cannot be covered quietly — any meaningful covering attempt into a float of ~2.25 million shares with aligned holders not selling will be immediately visible in price action.
View on StockTwits ↗$LNAI So today is gonna be like yesterday? Right after the market open is gonna go lowest and then pump? This kinda look like market manipulation and i hope it's not a trap. What do you think guys?
View on StockTwits ↗$LNAI Someone borrowing 2,000 shares at 413% annualised against a position they cannot cover, in a stock with confirmed zero borrow, is obviously not in a strong negotiating position. Shortablestocks shows 2,000 shares available at 08:03:21 UTC. Fintel's next polling interval (every 30 minutes) captures the snapshot at approximately 08:20–08:30 UTC — by which point the remaining 13,000 shares had already been withdrawn, leaving only the 2,000 that were borrowed visible as 0 available. Fintel then shows the prior peak of 15,000 as the "last change" figure because that was the last time availability actually changed to a non-zero number — which is consistent with their stated methodology of only displaying changes. So the complete picture is probably: 15,000 shares offered initially (Fintel's 05:50 reading or an earlier snapshot) 2,000 borrowed at 08:03:21 (Shortablestocks confirms the transaction) 13,000 withdrawn — within the same 30-minute Fintel polling window By the next Fintel read: 0 available, hence Fintel shows the change to 0 at 07:24 Both sources are likely correct. They are capturing different moments in the same sequence.
View on StockTwits ↗$LNAI Zero to borrow - again :) They were only available for a short time, if at all. I think this could be a plausible and coherent explanation. (my interpretation) Appears at 05:50 UTC Monday morning, before any market opens, before any trader would need a locate. Rate set at exactly 413.22% — start, min, max, latest all identical, meaning the rate never moved during the 95-minute window... It disappears again at 07:24 UTC — still well before any market opens. No FINRA short volume spike on Monday June 22, that would indicate anyone actually borrowed at that rate If someone had borrowed those 15,000 shares to establish a new short position going into Monday's open, you would expect to see it show up in the June 22 FINRA data. The June 22 short ratio of 43.67% on 439,859 total volume is actually below the prior period averages — not consistent with aggressive new short selling at 413% borrow cost. So the most Occam's Razor reading: a lender put 15,000 shares up at 413% to plant a price signal — "this is what borrow costs now" — and then withdrew them. Nobody paid 413% for 15,000 shares. I believe the purpose was never to lend. It was to set a reference rate on the public feed that any short seller monitoring the borrow market would see and interpret correctly. The message: if you want to borrow $LNAI, the floor is 413%. And the supply to do it with is essentially nothing. Whether this was a sophisticated holder making a statement, or a broker testing the market, the effect is the same — it repriced the cost of being short without actually facilitating any new short positions. A ghost offer rather than a genuine one.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.